Henry Schein, Inc.
HSICNASDAQHealthcareMedical Distribution
As of Oct 22, 2026 close
- Market cap
- $9.84B
- P/E (TTM)
- 24.41
- Forward P/E
- 24.19
- Dividend yield
- -
- 52-week range
- $62.15$92.18
- Volume (live)
- -
- Avg. volume (3M)
- 1.28M
Henry Schein (HSIC) Stock Price & Financial Analysis
Henry Schein Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $84.81 - $86.26 |
|---|---|
| 52-Week High | $92.18 |
| 52-Week Low | $62.15 |
| Open | $84.81 |
| Volume (last close) | 2.08M |
| Average Volume (3M) | 1.28M |
| Revenue (TTM) | 13.60B |
|---|---|
| Net Income (TTM) | 403.00M |
| Free Cash Flow (TTM) | 513.00M |
| EPS (TTM) | $3.43 |
| Profit Margin | 2.96% |
| Operating Margin | 5.69% |
| Return on Equity (ROE) | 12.77% |
| Debt to Equity | 1.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 9.84B |
|---|---|
| Shares Outstanding | 114.39M |
| P/E Ratio (TTM) | 24.41 |
| Forward P/E | 24.19 |
| Price to Sales (P/S) | 0.72 |
| Price to Book (P/B) | 3.12 |
| EV/EBITDA | 12.94 |
| 50-Day MA | $87.23 |
|---|---|
| 200-Day MA | $80.76 |
| 1-Year Change | +35.24% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Henry Schein at a Glance
As of the Oct 22, 2026 close, Henry Schein (HSIC) has a market capitalization of $9.84B. The stock trades at 24.4× trailing earnings, 24.2× forward earnings and 0.7× sales. Over the trailing twelve months it earned $403.00M on revenue of $13.60B (a 3.0% profit margin) and generated $513.00M of free cash flow. Revenue grew 6.5% year over year.
As of its latest reported balance sheet, it holds $157.00M in cash and securities against $3.46B of debt, a net debt position of $3.31B.
Henry Schein does not currently pay a dividend.
The share price is up 35.2% over the past year. At $86.00 (the Oct 22, 2026 close) it sits within its 52-week range of $62.15 to $92.18, above its 200-day moving average of $80.76.
Based on 18 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $98.13, 14.1% above the Oct 22, 2026 close.
Frequently Asked Questions About Henry Schein
What is the current stock price for HSIC?
As of the Oct 22, 2026 close, HSIC stock trades at $86.00. The 52-week range is $62.15–$92.18, with a day range of $84.81–$86.26.
What is the P/E ratio for HSIC?
As of the Oct 22, 2026 close, Henry Schein's trailing twelve-month (TTM) P/E ratio is 24.4, meaning investors pay $24.4 for every $1 of annual earnings. The forward P/E is 24.2, reflecting analyst expectations for future earnings. Henry Schein operates in the Healthcare sector.
Does HSIC pay dividends?
Henry Schein does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for HSIC?
Based on ratings from 18 professional analysts over the last 90 days, the consensus for HSIC is Buy. The average 12-month price target is $98.13, a 14.1% upside from the Oct 22, 2026 close of $86.00.
What is the market cap of HSIC?
As of the Oct 22, 2026 close, Henry Schein's market capitalization is $9.84B, classifying it as a mid-cap company. Henry Schein operates in the Healthcare sector within the Medical Distribution industry.